| Structure | Chemical Name | CAS | MF |
|
6-CHLORO-IMIDAZO[1,2-B]PYRIDAZIN-3-AMINE
|
166176-45-0
|
C6H5ClN4
|
|
Imidazo[1,2-b]pyridazin-3-ylamine
|
166176-46-1
|
C6H6N4
|
|
7-ACD
|
166176-51-8
|
C14H15Cl2N5O3S
|
|
3-(CHLOROMETHYL)-5-(4-FLUOROPHENYL)-1,2,4-OXADIAZOLE
|
166179-37-9
|
C9H6ClFN2O
|
|
Isoxazole, 3-ethoxy-4-methyl-5-(2-thienyl)- (9CI)
|
166180-41-2
|
C10H11NO2S
|
|
4-Isoxazolecarboxaldehyde,3-ethoxy-5-phenyl-(9CI)
|
166180-44-5
|
C12H11NO3
|
|
5-Isoxazolemethanol,3-ethoxy-4-methyl-(9CI)
|
166180-69-4
|
C7H11NO3
|
|
3(2H)-Isoxazolone,4-methyl-5-(2-oxazolyl)-(9CI)
|
166180-71-8
|
C7H6N2O3
|
|
Isoxazole, 3-ethoxy-4-methyl-5-(2-thiazolyl)- (9CI)
|
166180-75-2
|
C9H10N2O2S
|
|
Isoxazole, 3-ethoxy-4-methyl-5-phenyl- (9CI)
|
166180-83-2
|
C12H13NO2
|
|
IPRAVACAINE
|
166181-63-1
|
C18H26N2O
|
|
5-AMINO-1-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID METHYL ESTER
|
166182-90-7
|
C7H10N2O2
|
|
CRGDFPASSC
|
166184-23-2
|
C41H61N13O15S2
|
|
Piperazine, 1-methyl-4-[(methylamino)acetyl]- (9CI)
|
166187-00-4
|
C8H17N3O
|
|
2-Pyrrolidinecarboxamide,4-hydroxy-,(2R-cis)-(9CI)
|
166187-01-5
|
C5H10N2O2
|
|
2-Pyrrolidinecarboxamide,4-hydroxy-,(2R-trans)-(9CI)
|
166187-02-6
|
C5H10N2O2
|
|
TYROSINASE (206-214) (HUMAN)
|
166188-11-0
|
C61H83N15O10
|
|
2,5-Cyclohexadiene-1-methanol,2-methyl-1-(1-methylethyl)-(9CI)
|
166188-53-0
|
C11H18O
|
|
4H-1,2,4-Triazole-4-acetic acid, 3-methyl-, hydrazide
|
166189-64-6
|
C5H9N5O
|
|
1,3,5-Triazabicyclo[3.1.0]hexane,6-ethyl-3-nitro-(9CI)
|
166192-72-9
|
C5H10N4O2
|
|
Spiro[bicyclo[3.1.0]hexane-2,2-[1,3]dioxolane], 6-methylene-
|
166193-02-8
|
C9H12O2
|
|
3-TERT-BUTOXYCARBONYLAMINO-3-PYRIDIN-3-YL-PROPIONIC ACID
|
166194-68-9
|
C13H18N2O4
|
|
3-AMINO-4-(3-METHOXYPHENYL)BUTANOIC ACID
|
166194-73-6
|
C11H15NO3
|
|
3-Amino-2-hydroxyhexanoic acid
|
166196-05-0
|
C6H13NO3
|
|
1-[(2,6-Difluorophenyl)methyl]-1H-1,2,3-triazole-4-carboxylic acid
|
166196-11-8
|
C10H7F2N3O2
|
|
TOTO 3
|
166196-17-4
|
C53H62IN6S2+3
|
|
2-(4-bromo-1H-pyrazol-5-yl)pyridine(SALTDATA: FREE)
|
166196-52-7
|
C8H6BrN3
|
|
4-(4-bromo-1H-pyrazol-3-yl)pyridine
|
166196-54-9
|
C8H6BrN3
|
|
5-(3-CHLORO-2-THIENYL)-1H-PYRAZOLE
|
166196-59-4
|
C7H5ClN2S
|
|
3-(5-Chlorothien-2-yl)-1H-pyrazole
|
166196-61-8
|
C7H5ClN2S
|
|
5-(5-BROMO-2-THIENYL)-1H-PYRAZOLE
|
166196-67-4
|
C7H5BrN2S
|
|
2-(1H-pyrazol-5-yl)thiazole
|
166196-73-2
|
C6H5N3S
|
|
1-(3-CHLORO-2-THIENYL)-3-(DIMETHYLAMINO)-2-PROPEN-1-ONE
|
166196-77-6
|
C9H10ClNOS
|
|
1-(5-CHLORO-2-THIENYL)-3-(DIMETHYLAMINO)-2-PROPEN-1-ONE
|
166196-78-7
|
C9H10ClNOS
|
|
1-(3-BROMO-2-THIENYL)-3-(DIMETHYLAMINO)-2-PROPEN-1-ONE
|
166196-82-3
|
C9H10BrNOS
|
|
1-(2-Chloropyridin-3-yl)-3-(dimethylamino)prop-2-en-1-one
|
166196-84-5
|
C10H11ClN2O
|
|
4-CHLORO-(3-PYRAZOLYL)-6-METHYL PYRIMIDINE
|
166197-06-4
|
C8H7ClN4
|
|
Desdiacetyl-8-oxo FaMciclovir
|
166197-79-1
|
C10H15N5O3
|
|
N4-Benzoyl-7'-OH-Morpholino cytosine tosylate salt
|
166239-52-7
|
C23H26N4O7S
|
|
1,4:6,10-Diepoxy-2H-cycloheptdoxepin-5,9(1H,4H)-dione, 5a,6,10,10a-tetrahydro-, 1S-(1.alpha.,4.alpha.,5a.beta.,6.alpha.,10.alpha.,10a.beta.)-
|
166241-44-7
|
C11H10O5
|
|
5-Quinolinecarbonyl chloride, 8-hydroxy- (9CI)
|
166242-16-6
|
C10H6ClNO2
|
|
Amines, hydrogenated tallow alkyl, reaction products with tetrakis(hydroxymethyl)phosphonium chloride and urea
|
166242-53-1
|
|
|
7-DEAZA-7-IODO-2'-DEOXYADENOSINE
|
166247-63-8
|
C11H13IN4O3
|
|
4-METHYL-PIPERIDINE-1,2-DICARBOXYLIC ACID 1-BENZYL ESTER
|
166249-84-9
|
C15H19NO4
|
|
4-CHLORO-6-FLUOROINDAN-1-ONE
|
166250-01-7
|
C9H6ClFO
|
|
Benzenebutanoyl chloride, 2-fluoro-
|
166251-26-9
|
C10H10ClFO
|
|
3-(4-FLUORO-2-METHYL-PHENYL)-PROPIONIC ACID
|
166251-34-9
|
C10H11FO2
|
|
[4,6-Dihydroxy-5-[3-(triethoxysilyl)propyl]-1,3-phenylene]bis[phenylmethanone]
|
166255-23-8
|
C29H34O7Si
|
|
Pyridine, 4-(triethoxysilyl)- (9CI)
|
166262-04-0
|
C11H19NO3Si
|
|
1-(4-nitrophenyl)-1,2,2-triphenylethylene
|
166264-70-6
|
C26H19NO2
|
|
2(3H)-Furanone,3-ethyldihydro-3-(1-methylethyl)-(9CI)
|
166265-17-4
|
C9H16O2
|
|
2(3H)-Thiophenone,3-ethyldihydro-3-(1-methylethyl)-(9CI)
|
166265-18-5
|
C9H16OS
|
|
5-Iodo-3-methyl-2-pyridinamine
|
166266-19-9
|
C6H7IN2
|
|
(2-AMINO-4-METHYL-6-OXO-1,6-DIHYDRO-PYRIMIDIN-5-YL)-ACETIC ACID
|
166267-96-5
|
C7H9N3O3
|
|
H-PRA-OME HCL
|
166271-28-9
|
C6H10ClNO2
|
|
Carbamic acid, (3-hydroxy-1,1-dimethylbutyl)-, methyl ester (9CI)
|
166271-53-0
|
C8H17NO3
|
|
4-CHLORO-3-HYDROXY-BENZOIC ACID METHYL ESTER
|
166272-81-7
|
C8H7ClO3
|
|
N-({2-[(2-methylphenoxy)acetyl]hydrazino}carbonothioyl)-2-furamide
|
166274-69-7
|
C15H15N3O4S
|
|
L-erythro-Pentonic acid, 2-deoxy-2,2-difluoro-,γ-lactone
|
166275-25-8
|
C5H6F2O4
|
|
2-Deoxy-3,5-bis-O-[(1,1-diMethylethyl)diMethylsilyl]-2,2-difluoro-L-erythro-pentonic acid γ-lactone
|
166275-26-9
|
C17H34F2O4Si2
|
|
2-Bromo-4,5-difluorophenol
|
166281-37-4
|
C6H3BrF2O
|
|
2-AMINO-3-BUTENOIC ACID TRIFLUOROACETATE SALT
|
166301-19-5
|
C6H8F3NO4
|
|
N-PALMITOYL-D-SPHINGOSINE 1-BENZOATE
|
166301-20-8
|
C41H71NO4
|
|
1,3-Dioxane, 5-methyl-2-(2-methylpropyl)-, cis-
|
166301-22-0
|
C9H18O2
|
|
4-Phenylnaphthalene-1-sulfonic acid
|
166302-80-3
|
C16H12O3S
|
|
4-CHLORO-1-OXO-1-(3-TRIFLUOROMETHYLPHENYL)BUTANE
|
166312-46-5
|
C11H10ClF3O
|
|
2-methoxy-4-(trifluoromethyloxy)phenol
|
166312-49-8
|
C8H7F3O3
|
|
ETHYL 4-OXO-4-(3-TRIFLUOROMETHYLPHENYL)BUTYRATE
|
166312-68-1
|
C13H13F3O3
|
|
1H-Pyrazole-5-carboxylicacid,4-hydroxy-1,3-dimethyl-,methylester(9CI)
|
166315-80-6
|
C7H10N2O3
|
|
RHODIZONIC ACID, DISODIUM SALT DIHYDRATE
|
166316-02-5
|
C6H4Na2O8
|
|
4-(2-CARBOXYETHYL)BENZENEBORONIC ACID
|
166316-48-9
|
C9H11BO4
|
|
2-[(1E,3Z)-3-CHLORO-5-(1-DECYL-3,3-DIMETHYL-1,3-DIHYDRO-2H-INDOL-2-YLIDENE)-1,3-PENTADIENYL]-1-DECYL-3,3-DIMETHYL-3H-INDOLIUM PERCHLORATE
|
166317-60-8
|
C45H66Cl2N2O4
|
|
2-Pyrrolidinecarboxaldehyde,1-(4-methyl-3-pentenyl)-,(2S)-(9CI)
|
166317-93-7
|
C11H19NO
|
|
Furo[3,4-d]oxazole-2,4-dione, tetrahydro-3a-methyl-, cis- (9CI)
|
166318-57-6
|
C6H7NO4
|
|
Oxiraneacetic acid, alpha-amino-alpha-methyl-, (R*,S*)- (9CI)
|
166318-68-9
|
C5H9NO3
|
|
Oxiraneacetic acid, alpha-amino-alpha-methyl-, (R*,R*)- (9CI)
|
166318-69-0
|
C5H9NO3
|
|
(R)-Potassium warfarin
|
166320-52-1
|
|
|
(S)-Potassium warfarin
|
166320-53-2
|
|
|
9-O-Feruloyl-5,5'-dimethoxylariciresil
|
166322-14-1
|
C32H36O11
|
|
Bicyclo[1.1.0]butanone, 1,3-bis(1-methylethyl)- (9CI)
|
166325-45-7
|
C10H16O
|
|
Benzenemethanol, 4-hydroxy--alpha-,2-dimethyl- (9CI)
|
166327-54-4
|
C9H12O2
|
|
2,5-Cyclohexadien-1-one, 4-hydroxy-3-(1-hydroxyethyl)-4-methyl-, [R-(R*,S*)]-
|
166327-63-5
|
C9H12O3
|
|
2,5-Cyclohexadien-1-one, 4-hydroxy-3-(1-hydroxyethyl)-4-methyl-, [R-(R*,R*)]-
|
166327-64-6
|
C9H12O3
|
|
POTASSIUM (1-NAPHTHALENE)TRIFLUOROBORATE
|
166328-07-0
|
C10H7BF3K
|
|
POTASSIUM 4-(TRIFLUOROMETHYL)PHENYLTRIFLUOROBORATE
|
166328-08-1
|
C7H4BF6K
|
|
POTASSIUM 3,5-BIS(TRIFLUOROMETHYL)PHENYLTRIFLUOROBORATE
|
166328-09-2
|
C8H3BF9K
|
|
POTASSIUM (2-FLUOROPHENYL)TRIFLUOROBORATE
|
166328-10-5
|
C6H4BF4K
|
|
Potassium 2-furantrifluoroborate
|
166328-14-9
|
C4H3BF3O.K
|
|
2-FLUORO-5-METHYLPHENYLBORONIC ACID
|
166328-16-1
|
C7H8BFO2
|
|
TERT-BUTYL 2-(BROMOMETHYL)PHENYLCARBAMATE
|
166329-43-7
|
C12H16BrNO2
|
|
(Bromomethyl)boronic Acid Pinacol Ester
|
166330-03-6
|
C7H14BBrO2
|
|
(OXYDI-2,1-PHENYLENE)BIS(DIPHENYLPHOSPHINE)
|
166330-10-5
|
C36H28OP2
|
|
2-Chloro-6-isopropylnicotinic acid
|
166331-65-3
|
C9H10ClNO2
|
|
Methanol, fluoro-, benzoate (9CI)
|
166331-78-8
|
C8H7FO2
|
|
2-Furancarboxylicacid,fluoromethylester(9CI)
|
166331-79-9
|
C6H5FO3
|
|
1H-Imidazole-1-carboxylicacid,fluoromethylester(9CI)
|
166331-84-6
|
C5H5FN2O2
|
|
Cyclohexanecarboxylic acid, fluoromethyl ester (9CI)
|
166331-85-7
|
C8H13FO2
|
|
5-methylpyridine-3-sulfonyl chloride
|
166337-57-1
|
C6H6ClNO2S
|
|
3-BroMo-N-phenylbenzenesulfonaMide, 97%
|
166338-06-3
|
C12H10BrNO2S
|
|
Benzenemethanol, alpha-ethyl-4-fluoro-, (alphaR)- (9CI)
|
166371-89-7
|
C9H11FO
|